After demonstrating the expression of NLRP1 protein in three different breast cancer cells and highlighting its dramatic upregulation in MDA-MB-231 cells, we investigated whether COX-2 enzyme inhibitors affect the expression of NLRP1 inflammasomal components in MDA-MB-231 cells. Here, NLRP1 is linked to breast carcinoma.